pharmaphorum

DECEMBER 28, 2022

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. Conducting internal pre-sale checks and looking at your level of compliance and licenses is a vital exercise. It is also an ideal opportunity to simplify as well as harmonise.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio.

Marketing 69

Marketing Pharmaceutical Leads Manufacturing 69

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 billion) in total sales in 2021 and is expected to grow 1.1% Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio.

Pharmaceutical 52

Pharmaceutical Leads Marketing Manufacturing 52

World of DTC Marketing

MARCH 15, 2021

The study found that of the various high R&D manufacturing industries, the telephone industry retains 61% of total spending, the auto industry retains 68% and the computer industry retains 67%. One exception is Moderna, a relatively new pharmaceutical company which had no approved products for sale as recently as 2019.

Pharma 180

Pharma Sales Manufacturing Retail 180